{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "EGFR",
        "Protein_Change": {
          "ref": "L166P",
          "alt": "L166P",
          "position": "858"
        },
        "variant_string_id": "EGFR L166P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The L166P mutation causes severe structural destabilization, suggesting its role in Parkinson's.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly links the structural change to the disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Basic controls (wild-type, known loss-of-function mutant) were used.",
          "judgment": "Yes",
          "reasoning": "The paper provides controls for the mutation, indicating applicability."
        },
        {
          "next_step_or_outcome": "Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Statistical analysis and OddsPath calculations were performed.",
          "judgment": "Yes",
          "reasoning": "The paper includes statistical data, supporting the assessment."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "OddsPath value calculated (e.g., 2.0) indicates moderate pathogenicity.",
          "judgment": "Yes",
          "reasoning": "Using ACMG guidelines, the strength is PS3_moderate."
        }
      ],
      "final_evidence_strength": {
        "type": "PS3_moderate",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The L166P mutation shows moderate pathogenicity due to structural destabilization and statistical analysis."
    },
    {
      "variant_id": {
        "Gene": "EGFR",
        "Protein_Change": {
          "ref": "E64D",
          "alt": "E64D",
          "position": "117"
        },
        "variant_string_id": "EGFR E64D"
      },
      "functional_evidence_aim": "Benign",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The E64D mutation is nearly unperturbed, indicating its benign nature.",
          "judgment": "Yes",
          "reasoning": "The paper states the mutation is near wild-type, suggesting benign effects."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Basic controls (wild-type, known loss-of-function mutant) were used.",
          "judgment": "Yes",
          "reasoning": "The paper provides controls for the mutation, indicating applicability."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Statistical analysis and OddsPath calculations were performed.",
          "judgment": "Yes",
          "reasoning": "The paper includes statistical data, supporting the assessment."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "OddsPath value calculated (e.g., 2.0) indicates moderate pathogenicity.",
          "judgment": "Yes",
          "reasoning": "Using ACMG guidelines, the strength is PS3_moderate."
        }
      ],
      "final_evidence_strength": {
        "type": "PS3_moderate",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The E64D mutation is benign as it shows moderate pathogenicity through statistical analysis."
    },
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "M26I",
          "alt": "M26I",
          "position": "235"
        },
        "variant_string_id": "DJ-1 M26I"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The M26I mutation causes structural changes, suggesting its role in Parkinson's.",
          "judgment": "Yes",
          "reasoning": "The paper links structural changes to the disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Basic controls (wild-type, known loss-of-function mutant) were used.",
          "judgment": "Yes",
          "reasoning": "The paper provides controls for the mutation, indicating applicability."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Statistical analysis and OddsPath calculations were performed.",
          "judgment": "Yes",
          "reasoning": "The paper includes statistical data, supporting the assessment."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "OddsPath value calculated (e.g., 2.0) indicates moderate pathogenicity.",
          "judgment": "Yes",
          "reasoning": "Using ACMG guidelines, the strength is PS3_moderate."
        }
      ],
      "final_evidence_strength": {
        "type": "PS3_moderate",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The M26I mutation shows moderate pathogenicity due to structural changes and statistical analysis."
    },
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "A104T",
          "alt": "A104T",
          "position": "435"
        },
        "variant_string_id": "DJ-1 A104T"
      },
      "functional_evidence_aim": "Benign",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The A104T mutation has a different structural effect, suggesting its benign nature.",
          "judgment": "Yes",
          "reasoning": "The paper states the mutation is benign, indicating no pathogenicity."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Basic controls (wild-type, known loss-of-function mutant) were used.",
          "judgment": "Yes",
          "reasoning": "The paper provides controls for the mutation, indicating applicability."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Statistical analysis and OddsPath calculations were performed.",
          "judgment": "Yes",
          "reasoning": "The paper includes statistical data, supporting the assessment."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "OddsPath value calculated (e.g., 2.0) indicates moderate pathogenicity.",
          "judgment": "Yes",
          "reasoning": "Using ACMG guidelines, the strength is PS3_moderate."
        }
      ],
      "final_evidence_strength": {
        "type": "PS3_moderate",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The A104T mutation is benign as it shows moderate pathogenicity through statistical analysis."
    }
  ]
}